Search Results 191-200 of 17527 for cannabis

  1. https://www.mayoclinic.org/spanish_organization_concepts.xml

  2. Olaparib and Cediranib Maleate in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

    The concurrent use of all herbal supplements is prohibited during the study (including, but not limited to, cannabis, St. John's wort, kava, ephedra [ma ...

  3. A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) - Mayo Clinic

    * The participant has used of any cannabis product or cannabidiol that is not in oral solution/capsule/tablet form, not obtained from a government-approved ...

  4. Publications - Todd A. Kellogg, M.D. - Mayo Clinic

    Cannabis use and bariatric surgery psychology practice: survey and insights. Surg Obes Relat Dis. 2021 Apr; 17 (4):701-710 Epub 2020 Dec 16. View PubMed ...

  5. Alprazolam (oral route) - Side effects & dosage - Mayo Clinic

    Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Carisoprodol; Carphenazine; Cetirizine; Chloral Hydrate; Chlordiazepoxide; Chlorpromazine; Chlorzoxazone ...

  6. A Study of BHV-3241 in Subjects with Multiple System Atrophy - Mayo Clinic

    Note: urine drug screen positive for cannabis is exclusionary unless the Investigator and Medical Monitor agree that the subject can abstain from use for ...

  7. Intravenous Ketamine For Treatment-Resistant Depression - Mayo Clinic

    * Use of methamphetamine, cocaine, or cannabis. Abuse of stimulant (s) within the prior 12 months * Any current substance use disorder (excluding nicotine ...

  8. A Study of BHV-3241 in Subjects with Multiple System Atrophy - Mayo Clinic

    Note: urine drug screen positive for cannabis is exclusionary unless the Investigator and. Medical Monitor agree that the subject can abstain from use for ...

  9. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    Subject has cannabis use either recreational or for medical reasons within 14 days prior to Baseline or any history of clinically significant (per ...

  10. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml